# A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The MIRTOS Study

Study · id `cardio:ct-nct02429271` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02429271](<https://clinicaltrials.gov/study/NCT02429271>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02429271

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 336 participants.

## Technical summary

Registry record NCT02429271. Randomized; single masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2019-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 336 participants (enrolled count; ClinicalTrials.gov record NCT02429271, source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)
- Start date: 2015-08 (registry gives no type) (ClinicalTrials.gov record NCT02429271, source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)
- Primary completion: 2019-02 (actual) (ClinicalTrials.gov record NCT02429271, source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)
- Completion: 2019-02 (actual) (ClinicalTrials.gov record NCT02429271, source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)
- Countries: Greece (ClinicalTrials.gov record NCT02429271, source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02429271-2019-11-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
- Acronym: MIRTOS
- Condition: Myocardial Infarction
- Condition: ST Segment Elevation Myocardial Infarction (STEMI)
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Intervention (Procedure): Percutaneous Coronary Intervention (PCI)
- Intervention (Procedure): Coronary Angiography
- Lead sponsor: Hellenic Cardiovascular Research Society
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial (`cardio:pubmed-32715996`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2610db6c34c3729dcaa399f37ca8a51ca813d47c00db8e19b8c97860d3756cd3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
